John A. Stalfort III is Director at Taysha Gene Therapies, Inc. (TSHA). They have made 3 open-market trades across 3 companies since 2021, most recently 2026-06-03.
3 open-market purchases totalling $2.3M since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.